Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Octant Bio
Octant Bio discovers and develops small-molecule drugs by measuring how human cell receptors respond to compounds and designing molecules that modulate multiple pathways. It uses synthetic biology…
Octant Bio
Octant Bio discovers and develops small-molecule drugs by measuring how human cell receptors respond to compounds and designing molecules that modulate multiple pathways. It uses synthetic biology…
TL;DR
Founded: 2017
Headquarters / Industry: Biotechnology
Platform: Navigator: synthetic biology + high-throughput chemistry + sequencing + AI/ML
Lead program: OCT-980 (RHO-associated retinitis pigmentosa) — entered Phase 1a in Q1 2026
Known funding: $115M total (Series A ~ $30M; Series B ~ $80M)
Company Overview
Problem Domain
Small-molecule therapeutics discovery for protein misfolding/mistrafficking diseases and other areas (genetic disease, oncology, metabolism, immunology).
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
$5.0M
Seed financing per Dealroom
$4.9M
Seed financing per Dealroom
$30.0M
$80.0M
Investor Signal
“Backed by a mix of prominent venture firms and strategic investors including Andreessen Horowitz, 8VC, Lux Capital, Catalio Capital Management, Allen & Company, and others.”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week